Among the HER2(−) group of tumors, the ERα(+)/PgR(−) cases show significantly lower PGR mRNA expression when compared to ER(+)/PgR(+) cancers, suggesting that in most cases the loss of PgR occurs before or during transcription [31]. The gene discussed is ESR1; the disease is cancer.